Xylathin Xylanase (#1)
| Source | SynBio Database |
|---|---|
| Organization | BASF + Verenium |
| Market status | On the market |
| Industry | Industrial |
| Value chain stage | Input |
| Intended consumer | Commercial |
| Production process | Closed Production |
| Business models | B2B |
| Product categories | Fuel and Energy |
| Biotech components | Enzyme |
| Organization type(s) | Public Company |
| Funding types | Shareholder Investment |
| Known funding amount | € 2,147,483,647 EUR |
| Country of production | Switzerland |
| Trading symbol | BAS |
| Trading exchange | ETR |
| Notes | Company information is for BASF, which aquired Verenium |